Teaching and learning disclaimer
Following the impact of the pandemic, we made changes to our teaching and assessment to ensure our current students could continue with their studies uninterrupted and safely. These changes included courses being taught through blended delivery, normally including some face-to-face teaching, online provision, or a combination of both across the year.
The teaching and assessment methods listed show what is currently planned for 2021 entry; changes may be necessary if, by the beginning of this course, we need to adapt the way we’re delivering them due to the external environment, and to allow you to continue to receive the best education possible safely and seamlessly.
The module will consist of two half day and four full day workshops where teaching from a range of clinical experts in the field will allow participants to explore evidence based practice and a range of salient issues in relation to SACT.
Learning and skills development activities are issued to enable participants to achieve modular outcomes and benchmark standards for the administration of SACT. This is further supported by opportunities to observe and participate in supervised SACT practice in the participants own workplace.
Topics covered include:
- The biology of cancer.
- Safe cytotoxic therapy in clinical practice.
- Conventional toxicity.
- Immunotherapy in clinical practice.
- Hormones in cancer care.
- Neutropenic sepsis.
- New and emerging therapies.
- Long term side effects.
- Psychosocial effects of cancer and its treatment.
- 3 reflective accounts.
1. 2000 word case study based upon a case encountered within the participants workplace who is undergoing SACT.
2. Practice Assessment: Clinical competency assessment in accordance with the UKONS Systemic Anti-Cancer Therapy (SACT) Competency Passport.